JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.07B |
| 2 |
Xtrackers MSCI EAFE Hedged Equity ETF
DBEF
|
+$1.82B |
| 3 |
AT&T
T
|
+$779M |
| 4 |
Gilead Sciences
GILD
|
+$774M |
| 5 |
Eli Lilly
LLY
|
+$590M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$1.06B |
| 2 |
MON
Monsanto Co
MON
|
+$890M |
| 3 |
CVS Health
CVS
|
+$779M |
| 4 |
SLB Ltd
SLB
|
+$600M |
| 5 |
Chevron
CVX
|
+$573M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.33% |
| 2 | Healthcare | 12.01% |
| 3 | Technology | 10.9% |
| 4 | Consumer Discretionary | 8.31% |
| 5 | Industrials | 7.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Elevance Health
ELV
$81.5B
| $383M | 0.09% |
2,330,799
-782,845
| -25% | -$125M |
|
|
LNKD
252
PUT
DELISTED
LinkedIn Corporation
LNKD
| $381M | 0.09% |
+1,844,928
| New | +$411M |
|
253
Equifax
EFX
$22B
| $381M | 0.09% |
3,922,652
-140,895
| -3% | -$13.7M |
|
254
Edgewell Personal Care
EPC
$1.3B
| $380M | 0.09% |
2,892,243
-909,108
| -24% | -$93.8M |
|
|
TRCO
255
DELISTED
TRIBUNE MEDIA COMPANY CLASS A
TRCO
| $380M | 0.09% |
7,123,240
-2,349,303
| -25% | -$131M |
|
256
Dollar General
DG
$28.4B
| $379M | 0.09% |
4,874,696
+1,753,714
| +56% | +$132M |
|
257
Snap-on
SNA
$21.5B
| $379M | 0.09% |
2,378,594
-12,999
| -0.5% | -$2.01M |
|
258
BioMarin Pharmaceuticals
BMRN
$11.9B
| $372M | 0.09% |
2,719,921
+1,174,260
| +76% | +$146M |
|
259
Ambev
ABEV
$47.9B
| $370M | 0.09% |
60,725,299
-4,153,280
| -6% | -$25.7M |
|
260
Baxter International
BAX
$12.8B
| $366M | 0.09% |
9,637,039
+698,914
| +8% | +$26.1M |
|
261
Stryker
SYK
$135B
| $361M | 0.09% |
3,778,930
-1,556,614
| -29% | -$148M |
|
262
State Street SPDR S&P Biotech ETF
XBI
$10B
| $359M | 0.08% |
4,273,515
+535,992
| +14% | +$41.7M |
|
263
Ball Corp
BALL
$17.5B
| $352M | 0.08% |
10,044,416
-652,858
| -6% | -$23.6M |
|
|
WPZ
264
DELISTED
Williams Partners L.P.
WPZ
| $352M | 0.08% |
7,262,774
+2,617,170
| +56% | +$136M |
|
265
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$3.54B
| $351M | 0.08% |
1,882,159
+780,365
| +71% | +$159M |
|
266
HCA Healthcare
HCA
$90.6B
| $350M | 0.08% |
3,862,462
+203,502
| +6% | +$16.3M |
|
267
Itaú Unibanco
ITUB
$89.8B
| $349M | 0.08% |
79,438,057
+11,568,831
| +17% | +$54.4M |
|
268
Amgen
AMGN
$209B
| $347M | 0.08% |
2,262,023
-607,055
| -21% | -$97.2M |
|
|
DFS
269
DELISTED
Discover Financial Services
DFS
| $345M | 0.08% |
5,982,048
+2,517,875
| +73% | +$148M |
|
270
Silgan Holdings
SLGN
$4.51B
| $344M | 0.08% |
13,036,978
+1,549,560
| +13% | +$42.9M |
|
|
LLL
271
DELISTED
L3 Technologies, Inc.
LLL
| $344M | 0.08% |
3,030,397
-214,206
| -7% | -$25.5M |
|
272
Ralph Lauren
RL
$22.4B
| $342M | 0.08% |
2,584,625
-513,518
| -17% | -$69.4M |
|
273
Synopsys
SNPS
$71.6B
| $342M | 0.08% |
6,744,843
+345,629
| +5% | +$16.8M |
|
|
STR
274
DELISTED
QUESTAR CORP
STR
| $338M | 0.08% |
16,152,932
-566,494
| -3% | -$12.9M |
|
|
FRC
275
DELISTED
First Republic Bank
FRC
| $334M | 0.08% |
5,305,653
-165,313
| -3% | -$10M |
|
Similar funds
JP Morgan Chase's Q2 2015 Portfolio in Review
As of Q2 2015, JP Morgan Chase held 4,397 positions worth $424B, down 3.4% from $439B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q2 2015 filing shows 356 new, 1,656 increased, 1,613 reduced and 411 closed positions. Its largest new stake was Fitbit, Inc. Class A common stock: 1,923,189 shares worth $73.5M. The largest sale was Johnson & Johnson, an estimated $1.06B.
By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 13% a quarter earlier, followed by Healthcare and Technology.
- JP Morgan Chase's largest Q2 2015 buy was Fitbit, Inc. Class A common stock: 1,923,189 shares worth $73.5M.
- JP Morgan Chase added most to State Street SPDR S&P 500 ETF Trust in Q2 2015, an estimated $2.07B increase.
- JP Morgan Chase's biggest Q2 2015 reduction was Johnson & Johnson, cutting an estimated $1.06B.
- JP Morgan Chase fully exited LORILLARD INC COM STK in Q2 2015, selling an estimated $342M.
- JP Morgan Chase's ten largest holdings make up 17% of its $424B portfolio in Q2 2015.
- JP Morgan Chase opened 356 new positions and closed 411 in Q2 2015.
- JP Morgan Chase's portfolio value fell 3.4% quarter-over-quarter to $424B.
Based on JP Morgan Chase's 13F filing for Q2 2015, filed 14 Aug 2015.